These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Plasma catecholamine responses to change of posture in alcoholics during withdrawal and after continued abstinence from alcohol. Eisenhofer G; Whiteside EA; Johnson RH Clin Sci (Lond); 1985 Jan; 68(1):71-8. PubMed ID: 3964731 [TBL] [Abstract][Full Text] [Related]
27. Elevated plasma homocysteine levels in patients treated with levodopa: association with vascular disease. Rogers JD; Sanchez-Saffon A; Frol AB; Diaz-Arrastia R Arch Neurol; 2003 Jan; 60(1):59-64. PubMed ID: 12533089 [TBL] [Abstract][Full Text] [Related]
28. [Homocysteine and cerebrovascular disease]. Sepúlveda-Sánchez JM; Matía-Francés R; Martínez-Salio A; González-de la Aleja-Tejera J; Rodríguez-Peña Marín M; Porta-Etessam J Rev Neurol; 2004 Feb 16-29; 38(4):347-58. PubMed ID: 14997460 [TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Møller J; Nielsen GM; Tvedegaard KC; Andersen NT; Jørgensen PE Scand J Clin Lab Invest; 2000 Oct; 60(6):491-9. PubMed ID: 11129065 [TBL] [Abstract][Full Text] [Related]
30. Reduced plasma levels of asymmetric di-methylarginine (ADMA) in patients with alcohol dependence normalize during withdrawal. Frieling H; Leitmeier V; Haschemi-Nassab M; Kornhuber J; Rhein M; Bleich S; Hillemacher T Eur Neuropsychopharmacol; 2012 Nov; 22(11):836-40. PubMed ID: 22507687 [TBL] [Abstract][Full Text] [Related]
31. Plasma homocysteine is elevated in patients with exfoliation syndrome. Vessani RM; Ritch R; Liebmann JM; Jofe M Am J Ophthalmol; 2003 Jul; 136(1):41-6. PubMed ID: 12834668 [TBL] [Abstract][Full Text] [Related]
34. Plasma concentrations of C-reactive protein and total homocysteine in relation to the severity and risk factors for cerebrovascular disease. Youssef MY; Mojiminiyi OA; Abdella NA Transl Res; 2007 Sep; 150(3):158-63. PubMed ID: 17761368 [TBL] [Abstract][Full Text] [Related]
35. Cardiovascular risk factors and metabolic syndrome in alcohol- and nicotine-dependent men and women. Jarvis CM; Hayman LL; Braun LT; Schwertz DW; Ferrans CE; Piano MR J Cardiovasc Nurs; 2007; 22(6):429-35. PubMed ID: 18090180 [TBL] [Abstract][Full Text] [Related]
36. Relationship between plasma homocysteine and the morphological and immunohistochemical study of carotid plaques in patients with carotid stenosis over 70%. Alvarez B; Yugueros X; Fernández E; Luccini F; Gené A; Matas M Ann Vasc Surg; 2012 May; 26(4):500-5. PubMed ID: 22520390 [TBL] [Abstract][Full Text] [Related]
37. Role of homocysteine in cerebrovascular disease. Hoque MM; Rahman MZ; Rahman MR Mymensingh Med J; 2008 Jul; 17(2 Suppl):S39-42. PubMed ID: 18946449 [TBL] [Abstract][Full Text] [Related]
38. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke. Coull BM; Malinow MR; Beamer N; Sexton G; Nordt F; de Garmo P Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839 [TBL] [Abstract][Full Text] [Related]
39. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease. Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345 [TBL] [Abstract][Full Text] [Related]
40. Vitamin supplementation normalizes total plasma homocysteine concentration but not plasma homocysteine redox status in patients with acute coronary syndromes and hyperhomocysteinemia. Andersson A; Jonasson T; Ohlin H; Lindgren A; Hultberg B Clin Chem Lab Med; 2002 Jun; 40(6):554-8. PubMed ID: 12211647 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]